BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of EUR 987.88 million. The enterprise value is 873.00 million.
Market Cap | 987.88M |
Enterprise Value | 873.00M |
Important Dates
The next estimated earnings date is Friday, July 18, 2025.
Earnings Date | Jul 18, 2025 |
Ex-Dividend Date | May 8, 2025 |
Share Statistics
Current Share Class | 97.46M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 77.73M |
Valuation Ratios
The trailing PE ratio is 34.60.
PE Ratio | 34.60 |
Forward PE | n/a |
PS Ratio | 7.55 |
PB Ratio | 6.02 |
P/TBV Ratio | 6.62 |
P/FCF Ratio | 30.50 |
P/OCF Ratio | 30.02 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.55, with an EV/FCF ratio of 26.96.
EV / Earnings | 30.58 |
EV / Sales | 6.69 |
EV / EBITDA | 21.55 |
EV / EBIT | 22.91 |
EV / FCF | 26.96 |
Financial Position
The company has a current ratio of 10.84
Current Ratio | 10.84 |
Quick Ratio | 8.31 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 206.82 |
Financial Efficiency
Return on equity (ROE) is 15.69% and return on invested capital (ROIC) is 13.13%.
Return on Equity (ROE) | 15.69% |
Return on Assets (ROA) | 11.48% |
Return on Invested Capital (ROIC) | 13.13% |
Return on Capital Employed (ROCE) | 22.02% |
Revenue Per Employee | 581,372 |
Profits Per Employee | 126,885 |
Employee Count | 225 |
Asset Turnover | 0.63 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.85% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -11.85% |
50-Day Moving Average | 9.83 |
200-Day Moving Average | 9.92 |
Relative Strength Index (RSI) | 48.11 |
Average Volume (20 Days) | 32 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of EUR 130.81 million and earned 28.55 million in profits. Earnings per share was 0.28.
Revenue | 130.81M |
Gross Profit | 95.24M |
Operating Income | 38.20M |
Pretax Income | 36.51M |
Net Income | 28.55M |
EBITDA | 39.78M |
EBIT | 38.20M |
Earnings Per Share (EPS) | 0.28 |
Balance Sheet
The company has 115.15 million in cash and n/a in debt, giving a net cash position of 115.15 million.
Cash & Cash Equivalents | 115.15M |
Total Debt | n/a |
Net Cash | 115.15M |
Net Cash Per Share | n/a |
Equity (Book Value) | 163.98M |
Book Value Per Share | 1.62 |
Working Capital | 136.31M |
Cash Flow
In the last 12 months, operating cash flow was 32.91 million and capital expenditures -521,875, giving a free cash flow of 32.38 million.
Operating Cash Flow | 32.91M |
Capital Expenditures | -521,875 |
Free Cash Flow | 32.38M |
FCF Per Share | n/a |
Margins
Gross margin is 72.81%, with operating and profit margins of 29.20% and 21.83%.
Gross Margin | 72.81% |
Operating Margin | 29.20% |
Pretax Margin | 27.91% |
Profit Margin | 21.83% |
EBITDA Margin | 30.41% |
EBIT Margin | 29.20% |
FCF Margin | 24.76% |
Dividends & Yields
This stock pays an annual dividend of 0.63, which amounts to a dividend yield of 6.85%.
Dividend Per Share | 0.63 |
Dividend Yield | 6.85% |
Dividend Growth (YoY) | 6.92% |
Years of Dividend Growth | 1 |
Payout Ratio | 61.94% |
Buyback Yield | -0.13% |
Shareholder Yield | 6.72% |
Earnings Yield | 2.89% |
FCF Yield | 3.28% |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
Last Split Date | May 18, 2022 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |